Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 89333771

Gabbr2 Mouse anti-Human, Rat, APC, Clone:S81-2, Abnova™

Catalog No. 89333771 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-333-771 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-333-771 Supplier Abnova Corporation Supplier No. MAB17003
Add to Cart
Add to Cart

Description

Mouse monoclonal antibody raised against partial recombinant rat Gabbr2.

Specifications

Antigen Gabbr2
Applications Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot
Classification Monoclonal
Clone S81-2
Conjugate APC
Description gamma-aminobutyric acid (GABA) B receptor 2
Dilution Immunocytochemistry
Immunofluorescence
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user.
Formulation In PBS, pH 7.4 (50% glycerol, 0.09% sodium azide)
Gene Gabbr2
Gene Alias Gpr51
Host Species Mouse
Immunogen Recombinant protein corresponding to amino acids 861-912 of rat Gabbr2.
Quantity 100 μg
Gene ID (Entrez) 83633
Target Species Human, Rat
Content And Storage Store at -20°C.
Product Type Antibody
Form Liquid
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.